Gene test identifies non-metastatic melanoma patients at high risk of recurrence
8/06/2013
Castle Biosciences Inc. announced that data from studies of its DecisionDx-Melanoma test were being presented on August 2nd 2013 at the Summer Academy Meeting of the American Academy of Dermatology (AAD)...
Scientists discover a molecular 'switch' in cancers of the testis and ovary - LIN28
8/06/2013
Cambridge scientists have identified an 'on/off' switch in a type of cancer which typically occurs in the testes and ovaries called 'malignant germ cell tumours'. The research was published on 1st August, in the journal Cancer Research. Malignant germ cell tumours arise in sperm- or egg-forming cells and usually occur in the reproductive organs, the testes or ovaries...
New GAO report on physician self-referral abuse in prostate cancer treatment
8/06/2013
ASTRO Chairman Michael L. Steinberg, MD, FASTRO, called attention to the Government Accountability Office's (GAO) striking report, "Medicare: Higher Use of Costly Prostate Cancer Treatment by Providers Who Self-Refer Warrants Scrutiny," that details clear mistreatment of patients who trusted their physicians to care for their prostate cancer. Dr...
Added benefit not proven for vandetanib in thyroid cancer
8/06/2013
Uncertain data / No conclusion on harm possible / Hint of positive effect in people aged under 65 years Vandetanib (trade name: Caprelsa) has been approved in Germany since February 2012 for the treatment of adult patients who have a particular form of aggressive thyroid cancer...
Indications of considerable added benefit for apixaban in atrial fibrillation
8/06/2013
Fewer strokes and embolisms than with ASA / Fewer deaths, strokes and bleeding events in people over the age of 65 years in comparison with warfarin The clot-inhibiting drug apixaban (trade name: Eliquis) has been approved in Germany since November 2012 for the prevention of embolism and stroke in adults with non-valvular atrial fibrillation...
Stemming Bleeding Caused by Warfarin
8/06/2013
Prothrombin complex concentrates (PCCs) are faster and more effective than fresh frozen plasma at reversing hemorrhage caused by the anti-coagulant warfarin, despite plasma being the most commonly used therapy...
Poorly controlled celiac disease could up lymphoma risk
8/06/2013
People who have poorly controlled celiac disease may have a higher risk of developing lymphoma, according to a study published in the journal Annals of Internal Medicine. Researchers from Sweden carried out a population-based cohort study of 7,625 patients with celiac disease (CD) between 2006 and 2008...
Celiacs may be at higher lymphoma risk
8/06/2013
People who have poorly controlled celiac disease may have a higher risk of developing lymphoma, according to a study published in the journal Annals of Internal Medicine. Researchers from Sweden carried out a population-based cohort study of 7,625 patients with celiac disease (CD) between 2006 and 2008...
Scientists find long-sought method to efficiently make ingenol a complex anticancer compound
8/06/2013
Scientists at The Scripps Research Institute (TSRI) have achieved the first efficient chemical synthesis of ingenol, a highly complex, plant-derived compound that has long been of interest to drug developers for its anticancer potential. The achievement will enable scientists to synthesize a wide variety of ingenol derivatives and investigate their therapeutic properties...
Scientists discover a molecular 'switch' in cancers of the testis and ovary - LIN28
8/06/2013
Cambridge scientists have identified an 'on/off' switch in a type of cancer which typically occurs in the testes and ovaries called 'malignant germ cell tumours'. The research was published on 1st August, in the journal Cancer Research. Malignant germ cell tumours arise in sperm- or egg-forming cells and usually occur in the reproductive organs, the testes or ovaries...